Germline Variant Burden in Multidrug Resistance Transporters Is a Therapy‐specific Predictor of Survival in Breast Cancer Patients

International Journal of Cancer - United States
doi 10.1002/ijc.32898
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Wiley

Related search

ABO Blood Group Is a Predictor of Survival in Patients With Laryngeal Cancer

Chinese Journal of Cancer
2016English

Cyclin-E Is a Strong Predictor of Endocrine Therapy Failure in Human Breast Cancer

Oncogene
Cancer ResearchGeneticsMolecular Biology
2003English

Germline Mutation in DNA ‐repair Genes Is Associated With Poor Survival in BRCA 1/2‐ Negative Breast Cancer Patients

Cancer Science
Cancer ResearchMedicineOncology
2019English

Starvation, Detoxification, and Multidrug Resistance in Cancer Therapy

Drug Resistance Updates
Cancer ResearchOncologyInfectious DiseasesPharmacology
2012English

Lymphovascular Invasion Is an Independent Predictor of Survival in Breast Cancer After Neoadjuvant Chemotherapy

Breast Cancer Research and Treatment
Cancer ResearchOncology
2016English

RAD50 Germline Mutations Are Associated With Poor Survival in BRCA1/2 -Negative Breast Cancer Patients

International Journal of Cancer
Cancer ResearchOncology
2018English

Multidrug Resistance Proteins (MRPs) and Cancer Therapy

AAPS Journal
Pharmaceutical Science
2015English

Nomograms to Estimate Long-Term Overall Survival and Breast Cancer-Specific Survival of Patients With Luminal Breast Cancer

Oncotarget
Oncology
2016English

A High Burden of Comorbid Conditions Leads to Decreased Survival in Breast Cancer

Gland Surgery
Surgery
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy